On-Demand CME Videos

'HowTo' Incorporate PDT into Your Daily Practice: Microlearning CME Activity

About

This 10-minute microlearning tutorial is designed to demonstrate 'HowTo' incorporate photodynamic therapy into clinical practice. 
 


This activity is supported by an educational grant from Biofrontera.

Availability

In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:

Release Date:

April 28, 2023

Expiration Date:

April 28, 2024

Learning Objectives

At the completion of this activity, participants should be better able to:

  • Describe the key data on photodynamic therapy to manage actinic keratosis

  • Identify patients with actinic keratosis for photodynamic therapy

  • Discuss strategies to optimize care of patients with actinic keratosis with photodynamic therapy

Intended Audience

This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.

Faculty
Neal
Neal Bhatia, MD

Director of Clinical Dermatology
Therapeutics Clinical Research
San Diego, CA

Jonathan
Jonathan Weiss, MD

Adjunct Assistant Clinical Professor of Dermatology
Emory University School of Medicine
Atlanta, GA

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and CMEsquared. The Institute is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The Institute for Continuing Healthcare Education designates this live and enduring activity for a maximum of 0.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures & Disclaimers

CONFLICTS OF INTEREST/DISCLOSURES

In accordance with the ACCME Standards for Commercial Support, balance, independence, objectivity, and scientific rigor are ensured in all CME activities. This requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with any ineligible companies. In addition, the content of this material has been approved by an independent peer reviewer. 

Disclosures are as follows:

Neal D. Bhatia, MD

Advisory Board/Consultant: Almirall, Biofrontera, Ferndale, Galderma, ISDIN, J & J, La Roche-Posay, Ortho, and SUN

Grant/Research Support: Almirall, Biofrontera, Ferndale, Galderma, ISDIN, J & J, La Roche-Posay, Ortho, and SUN

Speaker's Bureau: Almirall, Biofrontera, Ferndale, Galderma, ISDIN, J & J, La Roche-Posay, Ortho, and SUN

Jonathan Weiss, MD

Advisory Board/Consultant: AbbVie, Arcutis, Biofrontera, Bristol Myers Squibb, Cutera, Dermavant, Galderma, Incyte, LEO Pharma, Novartis, Ortho Dermatologics, UCB, Verrica

Grant/Research Support: AbbVie, Bausch, Biofrontera, Bristol Myers Squibb, Cutera, Dermavant, Galderma,  Novartis, Verrica

Speaker's Bureau: AbbVie, Arcutis, Dermavant, Galderma, LEO Pharma, Novartis, Ortho Dermatologics, Pfizer, Sanofi Regeneron

The planners have disclosed that they have no relevant financial relationships with any Ineligible Company in the past 24 months.  

The Institute discloses that all relevant conflicts have been satisfactorily mitigated.